Citi lowered the firm’s price target on Kenvue (KVUE) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated models in the beverages and home and personal care group. Citi favors ...

Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and ...

Despite Kenvue’s recent underperformance relative to the Dow, analysts remain moderately optimistic about the stock’s ...

Beyond oral care, Kenvue is aligning its strategy with the government’s Healthy China 2030 initiative, a national plan to ...

Tylenol-maker Kenvue Inc. spoke with Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller ...

(Reuters) -Kenvue's interim Chief Executive Officer Kirk Perry met Robert F. Kennedy Jr. to try and dissuade the U.S. health ...

Kenvue rushed to the defense of Tylenol, but the stock still suffered a record selloff on news that RFK Jr. will release a ...

If you have been watching Kenvue (KVUE) lately, there is a good chance the news has caught your attention. A series of ...

Study reveals gaps in cough management in India, emphasizing need for scientific evaluation, rational prescribing, and ...

Kenvue just opened its global headquarters right here in New Jersey. Who is Kenvue? Do they make Tylenol? What to know about ...

Shares of Kenvue fell more than 10% on Friday after a report that Health Secretary Robert F. Kennedy Jr. will likely link ...

Research based on over 22 lakh patient records highlights high antibiotic use, poor categorisation of cough, and the need for ...